Steven M. Kawut, MD, MS

Pulmonary Medicine
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Perelman
View 2 additional locations
Schedule onlineCall 215-615-5864
Penn Medicine Provider

About me

  • Director, Pulmonary Hypertension/Pulmonary Vascular Disease Program
  • Professor of Medicine (Pulmonary, Allergy and Critical Care)
  • Professor of Medicine in Biostatistics and Epidemiology

My education and training

  • Medical School: Yale University School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

115 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
i've been trying to get the best help i can for quite awhile now.
Anonymous
March 2026
he is smart, professional and takes the time to understand and plan for your concerns.
Anonymous
March 2026
i appreciate that dr. kawut listened to my concerns. he's also very nice.
Anonymous
March 2026
great doctor

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Kawut is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM Sex and hemodynamics in pulmonary arterial hypertension , Eur Respir J, 43(2): 2014,523-30

Goncharov DA, Kudryashova TV, Ziai H, Ihida-Stansbury K, DeLisser H, Krymskaya VP, Tuder RM, Kawut SM, Goncharova EA. mTORC2 coordinates pulmonary artery smooth muscle cell metabolism, proliferation and survival in pulmonary arterial hypertension , Circulation, 129(8): 2014,864-74

Whitman I, Patel VV, Soliman EZ, Bluemke DA, Praestgaard A, Jain A, Herrington D, Lima JAC, Kawut SM Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: The MESA - Right Ventricle Study , JACC: 2014,5435

Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JAC, Liu C-Y, Michos ED, Prince MR, Rabbani L, Rabinowitz D, Shimbo D, Shea S, Barr RG Pulmonary hyperinflation and left ventricular mass: The Multi-Ethic Study of Atherosclerosis COPD Study , Circulation, 127(14): 2013,1503-11

Grau M, Graham Barr R, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, Kawut SM Percent emphysema and right ventricular structure and function: The MESA Lung and MESA-RV Studies , Chest, 144(1): 2013,136-44

Fritz J, Blair C, Oudiz R, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM Baseline and follow-up six minute walk distance and BNP predict 2-year mortalilty in pulmonary arterial hypertension , Chest, 143(2): 2013,315-23

Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: The MESA-Right Ventricle Study , Circulation, 126(14): 2012,1681-8

Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, Kawut, SM, Halpern SD Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension , Chest, 141(1): 2012,20-6

Gabler NM, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials , Circulation, 126(3): 2012,349-56

View all publications